Outside North America, marijuana investors and business owners tend to focus on Germany, Poland and the United Kingdom as the major medical cannabis industry growth drivers.
ADVERTISEMENT
However, one market has the potential to outgrow them all and looks to be on track to do so in the near future.
Australia’s medical cannabis revenue is expected to grow from around $600 million (955.1 million Australian dollars) in 2024 to more than $1.2 billion by 2028, according to Prohibition Partners’ fifth edition of “The Global Cannabis Report.”
ADVERTISEMENT
For comparison, Australia’s projected total is more than half of the projected value of all medical cannabis sales in Europe ($2.2 billion) by 2028, with Germany’s sales accounting for
Read full article on Marijuana Business Daily
